Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells
Authors:
- 15 August 2008
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 58 (4) , 547-552
Abstract
Full length mRNA to a drug-inhibited cell surface NADH oxidase, tNOX or ENOX2, is present in both non-cancer and cancer cells but is translated only in cancer cells as alternatively spliced variants. ENOX2 is a growth-related protein of the external plasma membrane surface that is shed into the circulation and is inhibited by a series of quinone site inhibitors with anticancer activity. To test the possibility that ENOX2 expression might be important to early stages of non-cancer cell development, the expression of the protein was monitored in chicken embryos during their development. Polyclonal antisera to a 34 kDa human serum form of ENOX2 cross-immunoreactive with the drug-responsive NADH oxidase of chicken hepatoma cells was used. The protein was identified based on drug-responsive enzymatic activities and analyses by western blots. The drug-responsive activity was associated with plasma membranes and sera of early chicken embryos and with chicken hepatoma plasma membranes but was absent from plasma membranes prepared from livers or from sera of normal adult chickens and from late embryo stages. The findings suggest that ENOX2 may fulfill some functions essential to the growth of early embryos which are lost in late embryo stages and absent from normal adult cells but which then reappear in cancer.Keywords
This publication has 24 references indexed in Scilit:
- Alternative Splicing as the Basis for Specific Localization of tNOX, a Unique Hydroquinone (NADH) Oxidase, to the Cancer Cell SurfaceBiochemistry, 2007
- NADH Oxidase: A Multifunctional Ectoprotein of the Eukaryotic Cell Surface1998
- A 33.5-kDa Heat- and Protease-Resistant NADH Oxidase Inhibited by Capsaicin from Sera of Cancer PatientsArchives of Biochemistry and Biophysics, 1997
- NADH Oxidase Activity from Sera Altered by Capsaicin Is Widely Distributed among Cancer PatientsArchives of Biochemistry and Biophysics, 1997
- Isolation and Identification of a Protein with Capsaicin-Inhibited NADH Oxidase Activity from Culture Media Conditioned by Growth of HeLa CellsArchives of Biochemistry and Biophysics, 1996
- Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma linesEuropean Journal of Cancer, 1996
- HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinityBiochimica et Biophysica Acta (BBA) - General Subjects, 1995
- Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture.Proceedings of the National Academy of Sciences, 1995
- Inhibition of the NADH oxidase activity of plasma membranes isolated from xenografts and cell lines by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N?-(4-chlorophenyl)urea (LY 181984) correlates with drug susceptibility of growthProtoplasma, 1995
- An avian hepatoma cell line for the cultivation of infectious laryngotracheitis virus and for the expression of foreign genes with a mammalian promotorJournal of Virological Methods, 1993